Lillian L. Siu

AACR Project GENIE: Powering Precision Medicine through an International Consortium

Fabrice André, Mónica Arnedos, Alexander S. Baras et al. · Cancer Discovery · 2017 · 1.9K citations · Full text

Tumour heterogeneity in the clinic

Philippe L. Bédard, Aaron R. Hansen, Mark J. Ratain et al. · Nature · 2013 · 1.2K citations · Full text

Neuro-oncology, Tumoral Pathology, Tumor Heterogeneity +5

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

Manuel Hidalgo, Lillian L. Siu, John Nemunaitis et al. · Journal of Clinical Oncology · 2001 · 997 citations

Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Denis Soulières, Neil Senzer, Everett E. Vokes et al. · Journal of Clinical Oncology · 2003 · 803 citations · Full text

Toward understanding and exploiting tumor heterogeneity

Ash A. Alizadeh, Victoria Aranda, Alberto Bardelli et al. · Nature Medicine · 2015 · 749 citations · Full text

Tumor Heterogeneity, Cancer Genomics, Medicine +5